Sort
10,766 grants matching “checkpoint inhibitor”
Targeting Lung Cancer Vulnerabilities
$118,034John D Minna · Ut Southwestern Medical Center · P50 · FY2023 · CA
TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION
$117,913Alexander V Kabanov · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA
A physical sciences approach to investigate the role of exosomes in metastatic progression
$117,879Ravi Radhakrishnan · University Of Pennsylvania · U01 · FY2022 · CA
CXCL9/10 Macrophage Induced CXCR3+ T-cell Recruitment to the Heart Contributes to Immunotherapy Myocarditis
$117,863Han Zhu · Stanford University · R03 · FY2025 · HL
CXCL9/10 Macrophage Induced CXCR3+ T-cell Recruitment to the Heart Contributes to Immunotherapy Myocarditis
$117,804Han Zhu · Stanford University · R03 · FY2024 · HL
Intratumoral immunotherapy to enhance T cell infiltration and augment immune checkpoint blockade responses across molecular subtypes of breast cancer
$117,573Erika J Crosby · Duke University · K22 · FY2023 · CA
Harnessing neutrophils to improve the efficacy of immune checkpoint inhibitors in breast cancer
$117,311Yang Gao · Baylor College Of Medicine · K99 · FY2023 · CA
Intratumoral immunotherapy to enhance T cell infiltration and augment immune checkpoint blockade responses across molecular subtypes of breast cancer
$117,141Erika J Crosby · Duke University · K22 · FY2024 · CA
Mentoring Patient Oriented Research in the Microbiome of Cancer and Stem Cell Transplant Patients
$116,891Andrew Y Koh · Ut Southwestern Medical Center · K24 · FY2023 · AI
Complement as a modulator of immunosuppression and progression in Polycystic Kidney Disease
$116,625Katharina Hopp · University Of Colorado Denver · R03 · FY2021 · DK
Complement as a modulator of immunosuppression and progression in Polycystic Kidney Disease
$116,625Katharina Hopp · University Of Colorado Denver · R03 · FY2022 · DK
Functions of the LKB1 tumor suppressor in control in metabolism and epigenetics
$116,466Nabeel Bardeesy · Massachusetts General Hospital · R01 · FY2022 · CA
The effect of hydroxychloroquine treatment on immune checkpoint inhibitors
$116,464Tim Greten · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Role of myeloid-derived suppressor cells in local and systemic immunosuppression in glioblastoma
$116,034Defne Bayik Watson · University Of Miami School Of Medicine · R00 · FY2024 · CA
Resiliency Among Older Adults Receiving Lung Cancer Treatment (ROAR-LCT): A Pilot Intervention Study
$116,028Carolyn Presley · Ohio State University · R03 · FY2019 · AG
Resiliency Among Older Adults Receiving Lung Cancer Treatment (ROAR-LCT): A Pilot Intervention Study
$115,970Carolyn Presley · Ohio State University · R03 · FY2020 · AG
Computational Methods for Inferring Single-cell DNA Methylation and its Spatial Landscape
$115,909Wenpin Hou · Johns Hopkins University · K99 · FY2021 · HG
A physical sciences approach to investigate the role of exosomes in metastatic progression
$115,522Ravi Radhakrishnan · University Of Pennsylvania · U01 · FY2023 · CA
Mentoring Patient Oriented Research in the Microbiome of Cancer and Stem Cell Transplant Patients
$115,395Andrew Y Koh · Ut Southwestern Medical Center · K24 · FY2024 · AI
Mitomycin C (MC) and 10-decarbamoyl MC Signaling to p53 and Family Members
$114,957Jill E Bargonetti · Hunter College · S06 · FY2006 · GM
Cellular and molecular regulators of melanocyte regeneration
$114,906Craig Joseph Ceol · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · AR
Dual function of HSP70 in cytoprotection of tumor cells and generation of permissive microenvironment
$114,843Hasan Korkaya · Augusta University · R01 · FY2023 · CA
Targeting heme metabolism to initiate an immune response against breast cancer liver metastasis
$114,342Michelle M Williams · University Of Colorado Denver · K99 · FY2023 · CA
Targeting heme metabolism to initiate an immune response against breast cancer liver metastasis
$114,342Michelle M Williams · University Of Colorado Denver · K99 · FY2022 · CA
Translation of a novel combination therapy approach for non-Hodgkin lymphoma
$114,223Shruthi Naik · Mayo Clinic Rochester · U01 · FY2024 · CA